Apricus Biosciences, Inc. (Nasdaq: APRI) announced that its marketing application for Vitaros, indicated for the treatment of patients with erectile ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE